|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income tax benefit | |||||
| Litigation settlements and other contingencies, net | |||||
| Loss from equity method investments | |||||
| Loss on disposal of business | |||||
| Share-based compensation expense | |||||
| Acquired IPR&D | |||||
| Impairment of goodwill | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Trade accounts payable | |||||
| Income taxes | |||||
| Other operating assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Capital expenditures | |||||
| Payments for product rights and other, net | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchases of IPR&D | |||||
| Proceeds from sale of assets and subsidiaries | |||||
| Purchase of marketable securities | |||||
| Proceeds from the sale of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Payments of long-term debt | |||||
| Payments of financing fees | |||||
| Change in short-term borrowings, net | |||||
| Purchase of ordinary shares | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Contingent consideration payments | |||||
| Cash dividends paid | |||||
| Non-contingent payments for product rights | |||||
| Issuance of common stock | |||||
| Other items, net | |||||
| Net cash used in financing activities | |||||
| Effect on cash of changes in exchange rates | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash — beginning of period | |||||
| Cash, cash equivalents and restricted cash — end of period | |||||
| Supplemental disclosures of cash flow information — | |||||
| Cash paid during the period for: | |||||
| Income taxes | |||||
| Interest | |||||
Loading...